IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
197.27
+5.75 (3.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $35.80 billion as of December 20, 2024. Its market cap has decreased by -8.75% in one year.
Market Cap
35.80B
Enterprise Value
48.04B
1-Year Change
-8.75%
Ranking
Category
Stock Price
$197.27
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $35.80B, an increase of 556.04%. That is a compound annual growth rate of 17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 35.80B | -15.21% |
| Dec 29, 2023 | 42.23B | 10.96% |
| Dec 30, 2022 | 38.06B | -29.39% |
| Dec 31, 2021 | 53.90B | 56.91% |
| Dec 31, 2020 | 34.35B | 14.58% |
| Dec 31, 2019 | 29.98B | 27.57% |
| Dec 31, 2018 | 23.50B | 13.60% |
| Dec 29, 2017 | 20.69B | 10.50% |
| Dec 30, 2016 | 18.72B | 121.52% |
| Dec 31, 2015 | 8.45B | 12.33% |
| Dec 31, 2014 | 7.52B | 25.93% |
| Dec 31, 2013 | 5.97B | 9.47% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical | 41.62B |
| Agilent Technologies | 38.42B |
| argenx SE | 38.02B |
| Veeva Systems | 36.39B |
| GE HealthCare Technologies | 36.05B |
| ResMed | 34.82B |
| IDEXX Laboratories | 33.76B |
| Alnylam Pharmaceuticals | 31.66B |